Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis. (Q45350105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Giorgio La Nasa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Antonio Solinas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

F Murgia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

L Podda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

S Atzeni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

9 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

225-227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.235

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.235

Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.235

Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.235

Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.235

Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.235

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.235

Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.235

Ruxolitinib for myelofibrosis therapy: current context, pros and cons

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23929216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutations and prognosis in primary myelofibrosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23929216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2013.235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 March 2020

1031321114

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23929216%20AND%20SRC:MED&resulttype=core&format=json